Diabetic Foot Treatment
Diabetic foot is a consequence of diabetes without management or without adherence to treatment, and 80% of lower limb amputations correspond to this condition.
In alliance with Rokit, Elixym BioPharmaceutical has brought to Latin America a modern, effective, practical therapeutic solution with the possibility of 100% effectiveness against diabetic foot: fat patches in 3D printing, made to measure and with adipose tissue of the patient , to provide a solution to the consequence of this pathology in a shorter time and with greater results against diabetic ulcers.
DFU regeneration platform
DFURegen Platform delivers effective, customized regenerative therapy for treating diabetic foot ulcer by using autologous solution with our 4D disruptive technology. As a leading innovative company, ROKIT has brought a new paradigm in regenerative therapy enhancing both efficacy and safety proven through global clinical studies.
CHARACTERISTIC
No Immune Rejection
Mimic Native Structure Of Human Body
No Hospitalazation
No Amputation
AUTOLOGOUS ADIPOSE TISSUE
No Immune Rejection
4D BIOPRINTING TECHNOLOGY
Mimic Native Structure Of Human Body
ONE-TIME TREATMENT
No Hospitalazation
FAST WOUND CLOSURE PREVENT INFECTION
No Amputation
Contact Us
Elixym BioPharma
- Cll 124 #45-15 Office 301 Bogotá, COL
- +57 (601) 5 807 730
- servicioalcliente@elixymbiopharma.com.co
English 
Spanish